These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 38524137

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome.
    Eyler SJ, Meyer NC, Zhang Y, Xiao X, Nester CM, Smith RJ.
    Pediatr Nephrol; 2013 Nov; 28(11):2221-5. PubMed ID: 23880784
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. High prevalence of CFHR deletions in Indian women with pregnancy-associated hemolytic uremic syndrome.
    Kandari S, Chakurkar V, Gaikwad S, Agarwal M, Phadke N, Lobo V.
    Nephrology (Carlton); 2022 Mar; 27(3):231-237. PubMed ID: 34796567
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3/CFHR1 Gene Deletion.
    Ferrer F, Roldão M, Figueiredo C, Lopes K.
    Nephron; 2022 Mar; 146(2):185-189. PubMed ID: 34724668
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Anti-Factor H Antibody-Associated Atypical Hemolytic Uremic Syndrome: A Case Report.
    Abazi-Emini N, Sahpazova E, Putnik J, Tasic V.
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Oct 26; 42(2):109-115. PubMed ID: 34699711
    [Abstract] [Full Text] [Related]

  • 31. CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Zipfel PF, Wiech T, Stea ED, Skerka C.
    J Am Soc Nephrol; 2020 Feb 26; 31(2):241-256. PubMed ID: 31980588
    [Abstract] [Full Text] [Related]

  • 32. Eculizumab and Belatacept for De Novo Atypical Hemolytic Uremic Syndrome Associated With CFHR3-CFHR1 Deletion in a Kidney Transplant Recipient: A Case Report.
    Dedhia P, Govil A, Mogilishetty G, Alloway RR, Woodle ES, Abu Jawdeh BG.
    Transplant Proc; 2017 Feb 26; 49(1):188-192. PubMed ID: 28104134
    [Abstract] [Full Text] [Related]

  • 33. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene.
    Venables JP, Strain L, Routledge D, Bourn D, Powell HM, Warwicker P, Diaz-Torres ML, Sampson A, Mead P, Webb M, Pirson Y, Jackson MS, Hughes A, Wood KM, Goodship JA, Goodship TH.
    PLoS Med; 2006 Oct 26; 3(10):e431. PubMed ID: 17076561
    [Abstract] [Full Text] [Related]

  • 34. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
    Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Rabasco C, Espinosa M, Cavero T, Blasco M, Cao M, Manrique J, Cabello-Chavez V, Suñer M, Heras M, Fulladosa X, Belmar L, Sempere A, Peralta C, Castillo L, Arnau A, Praga M, Rodriguez de Cordoba S.
    Kidney Int; 2018 Feb 26; 93(2):450-459. PubMed ID: 28911789
    [Abstract] [Full Text] [Related]

  • 35. Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (CFH) gene family.
    Cantsilieris S, Nelson BJ, Huddleston J, Baker C, Harshman L, Penewit K, Munson KM, Sorensen M, Welch AE, Dang V, Grassmann F, Richardson AJ, Guymer RH, Graves-Lindsay TA, Wilson RK, Weber BHF, Baird PN, Allikmets R, Eichler EE.
    Proc Natl Acad Sci U S A; 2018 May 08; 115(19):E4433-E4442. PubMed ID: 29686068
    [Abstract] [Full Text] [Related]

  • 36. A Heterozygous CFHR3-CFHR1 Gene Deletion in a Pediatric Patient With Transplant-associated Thrombotic Microangiopathy Who was Treated With Eculizumab.
    Nozawa A, Ozeki M, Hori T, Kawamoto N, Hirayama M, Azuma E, Fukao T.
    J Pediatr Hematol Oncol; 2018 Nov 08; 40(8):e544-e546. PubMed ID: 28991129
    [Abstract] [Full Text] [Related]

  • 37. Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.
    Chaudhary P, Hepgur M, Sarkissian S, Smith RJ, Weitz IC.
    Blood Transfus; 2014 Jan 08; 12(1):111-3. PubMed ID: 24333077
    [No Abstract] [Full Text] [Related]

  • 38. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Osborne AJ, Breno M, Borsa NG, Bu F, Frémeaux-Bacchi V, Gale DP, van den Heuvel LP, Kavanagh D, Noris M, Pinto S, Rallapalli PM, Remuzzi G, Rodríguez de Cordoba S, Ruiz A, Smith RJH, Vieira-Martins P, Volokhina E, Wilson V, Goodship THJ, Perkins SJ.
    J Immunol; 2018 Apr 01; 200(7):2464-2478. PubMed ID: 29500241
    [Abstract] [Full Text] [Related]

  • 39. Atypical hemolytic uremic syndrome due to factor H autoantibody.
    Uslu-Gökceoğlu A, Doğan CS, Comak E, Koyun M, Akman S.
    Turk J Pediatr; 2013 Apr 01; 55(1):86-9. PubMed ID: 23692839
    [Abstract] [Full Text] [Related]

  • 40. Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration.
    Schmid-Kubista KE, Tosakulwong N, Wu Y, Ryu E, Hecker LA, Baratz KH, Brown WL, Edwards AO.
    Invest Ophthalmol Vis Sci; 2009 Nov 01; 50(11):5070-9. PubMed ID: 19553609
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.